0A88.LSE 10x Genomics, Inc.
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is 0A88.LSE undervalued?
Graham numberThe Graham number of 10x Genomics, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
10x Genomics, Inc. fundamental analysis
No fundamental analysis for 10x Genomics, Inc. yet.
10x Genomics, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About 10x Genomics, Inc.
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale sing…
Full company profileFinancial statements of 10x Genomics, Inc. are not available yet.
10x Genomics, Inc. dividends
10x Genomics, Inc. has not paid dividends in the last 4 fiscal years.
Who owns 10x Genomics, Inc.
- Insiders 1.44%
- Institutions 98.56%
- Public & others 0.00%
- Free float 118M
10x Genomics, Inc. company profile
- Company name
- 10x Genomics, Inc.
- Ticker
- 0A88.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 1,178
- Fiscal year end
- December
- Address
- 6230 Stoneridge Mall Road, Pleasanton, CA, United States, 94588-3260
- Phone
- 925 401 7300
- Website
- 10xgenomics.com
About 10x Genomics, Inc.
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
10x Genomics, Inc. management
9- Dr. Serge Saxonov Ph.D.Co-Founder, CEO & Director · born 1977
- Dr. Benjamin J. Hindson Ph.D.Co-Founder, President, Chief Scientific Officer & Director · born 1975
- Mr. Adam S. TaichCFO, Treasurer, Principal Financial Officer & Principal Accounting Officer · born 1975
- Mr. Jim GoodrichChief of Global Operations
- Mr. Michael Schnall-Levin Ph.D.Founding Scientist & CTO
- Ms. Cassie CorneauManager of Investor Relations & Strategic Finance
- Dr. Randy WuGeneral Counsel and Secretary
- Ms. Mennah MoustafaChief Commercial Officer
- Mr. Jens DurruthyAssociate Director of Product Management